cryptotanshinone has been researched along with Osteoarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, M; Su, X; Teng, J; Wang, J; Yue, S | 1 |
| Cheng, L; Feng, Z; Li, H; Li, X; Lin, J; Ni, W; Wu, A; Xie, C; Zheng, W | 1 |
2 other study(ies) available for cryptotanshinone and Osteoarthritis
| Article | Year |
|---|---|
Cryptotanshinone interferes with chondrocyte apoptosis in osteoarthritis by inhibiting the expression of miR‑574‑5p.
Topics: Animals; Apoptosis; Cell Proliferation; Chondrocytes; Down-Regulation; Genes, bcl-2; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Muscle Proteins; Osteoarthritis; Phenanthrenes; Repressor Proteins | 2021 |
Cryptotanshinone protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Disease Progression; Female; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Middle Aged; NF-kappa B; Nitric Oxide; Osteoarthritis; Phenanthrenes; Salvia miltiorrhiza; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |